Brief: Cero Therapeutics Holdings fails to regain compliance with Nasdaq MVLS requirement
01/11/2024 22:12
Nov 1 (Reuters) - CERo Therapeutics Holdings Inc
CERO.O :
* CERO THERAPEUTICS HOLDINGS INC - FAILS TO REGAIN
COMPLIANCE WITH
NASDAQ MVLS REQUIREMENT
Source text: ID:n0001213900-24-093570
Further company coverage: CERO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CERo Therapeutics Holdings
See all newsBrief: Cero Therapeutics Hearing Review Council Issued Decision
Brief: Cero Therapeutics Provides Clinical Update On Phase 1 Trial Of Cer-1236 In Aml (Certaint-1)
Brief: Cero Therapeutics Provides Clinical Update On Phase 1 Trial Of Cer-1236 In Aml
Brief: Cero Therapeutics Provides Clinical Update On Phase 1 Clinical Trial
Brief: Cero Therapeutics Holdings Inc - Continues To Evaluate Additional Options For Up-List